menu

Filling the need for trusted information on national health issues

Donate

Newsroom

In the News

Legal Challenges to the FDA Approval of Medication Abortion Pills

With a hearing on the case scheduled for March 15, this issue brief details the Alliance of Hippocratic Medicine challenge to the FDA’s approval of the abortion pill, mifepristone. It provides context for the challenge, as well as what some of the possible rulings in the case could mean for access to medication abortion.

States Are Employing a Range of Strategies As They Prepare to Resume Medicaid Disenrollments During the Unwinding

Out-of-Pocket Spending on Insulin Among People with Private Insurance

Medicare Advantage Insurers Report Much Higher Gross Margins Per Enrollee Than Insurers in Other Markets

Analysis Details the 30% of Federal Spending That Goes to Health Care Programs

Three Years of the covid-19 pandemic

Quick Take: Observations on the Third Anniversary of COVID Pandemic Declaration

The end of the COVID-19 public health emergency declaration in May comes on the heels of the third anniversary of the WHO first announcing the pandemic. Watch KFF’s Jen Kates explore the pandemic’s impact.

Ten Numbers to Mark Three Years of COVID-19

COVID-19 Cases, Deaths, and Vaccinations by Race/Ethnicity as of Winter 2022

The COVID-19 Pandemic: Insights from Three Years of KFF Polling

Three years in, we look at how the public has responded—from confusion on trusted sources to trust in public health officials, how partisanship played a role, vaccination trends, and the impact of the pandemic beyond health. Check out KFF’s key polling data.   

abortion in the u.s.

Legal Challenges to the FDA Approval of Medication Abortion Pills

This issue brief focuses on the major claims in the Alliance for Hippocratic Medicine (AHM) v. FDA case, which has enormous implications for access to medication abortion in the United States. Many of the issues raised in the brief will also be relevant to the other abortion cases involving the FDA and its role in approving and regulating mifepristone. 


Access the Abortion in the United States Dashboard

State and Federal Reproductive Rights Litigation Tracker

The Public Are Largely Confused About the Legality of Medication Abortion in Their States

The Availability and Use of Medication Abortion

Key Facts on Abortion in the United States

MEDIA CONTACTS

Racial equity and health policy, social impact media, KFF institutional
Rakesh Singh
Vice President of Communications, CA
(650) 854-9400
rsingh@kff.org

Medicare, Medicaid, the uninsured, Kaiser Health News
Chris Lee
Senior Communications Officer, DC
(202) 654-1403
clee@kff.org

For other media inquiries contact kffmedia@kff.org

Polling, health reform, health costs, private insurance
Craig Palosky
Director of Communications, DC
(202) 347-5270
cpalosky@kff.org

Women’s Health Policy, global health policy, COVID-19, HIV
Mikhaila Richards
Communications Officer, DC
(202) 347-5270
mrichards@kff.org

How to cite us

Staff Directory

Image for KFF Staff Directory

Latest from Kaiser Health News

More Kaiser Health News
events

Browse the Latest from KFF

The Henry J. Kaiser Family Foundation Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270

www.kff.org | Email Alerts: kff.org/email | facebook.com/KaiserFamilyFoundation | twitter.com/kff

Filling the need for trusted information on national health issues, the Kaiser Family Foundation is a nonprofit organization based in San Francisco, California.